Summary | It was only last year that GlaxoSmithKline Plc was
fined the equivalent of $500 million in China for bribing
officials to push its medicine sales.
fined the equivalent of $500 million in China for bribing
officials to push its medicine sales.
chinadaily.com.cn | 28 August 2015